Global B7-H4 Antibody Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global B7-H4 Antibody Market Research Report 2024
B7-H4 Antibody is an antibody directed against the B7-H4 protein in the human immune system.
According to Mr Accuracy reports’s new survey, global B7-H4 Antibody market is projected to reach US$ 894.4 million in 2029, increasing from US$ 394.6 million in 2022, with the CAGR of 12.4% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole B7-H4 Antibody market research.
B7-H4, also known as VTCN1, belongs to the B7 family of immune checkpoint molecules and is usually expressed in antigen-presenting cells, tumor cells and certain inflammation-related cells. Its role is to maintain immune balance by regulating T cell immune responses, thereby potentially suppressing excessive immune responses. B7-H4 antibodies can bind to B7-H4 molecules, and may play a role in regulating T cell activation, proliferation and suppressing immune responses. Therefore, this antibody has potential application prospects in the research of immune diseases, tumor therapy and other fields.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global B7-H4 Antibody market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Sino Biological, Inc.
LifeSpan BioSciences, Inc
Bio-Techne
BioLegend
Thermo Fisher
Abcam
Cell Signaling Technology, Inc.
CUSABIO
MyBiosource, Inc.
Biotium
Merck
Abeomics Inc.
HUABIO
Abbiotec
Segment by Type
Monoclonal Antibody
Polyclonal Antibody
Flow Cytometry
ELISA
Western Blot
Immunoprecipitation
Immunofluorescence
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The B7-H4 Antibody report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global B7-H4 Antibody market is projected to reach US$ 894.4 million in 2029, increasing from US$ 394.6 million in 2022, with the CAGR of 12.4% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole B7-H4 Antibody market research.
B7-H4, also known as VTCN1, belongs to the B7 family of immune checkpoint molecules and is usually expressed in antigen-presenting cells, tumor cells and certain inflammation-related cells. Its role is to maintain immune balance by regulating T cell immune responses, thereby potentially suppressing excessive immune responses. B7-H4 antibodies can bind to B7-H4 molecules, and may play a role in regulating T cell activation, proliferation and suppressing immune responses. Therefore, this antibody has potential application prospects in the research of immune diseases, tumor therapy and other fields.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global B7-H4 Antibody market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Sino Biological, Inc.
LifeSpan BioSciences, Inc
Bio-Techne
BioLegend
Thermo Fisher
Abcam
Cell Signaling Technology, Inc.
CUSABIO
MyBiosource, Inc.
Biotium
Merck
Abeomics Inc.
HUABIO
Abbiotec
Segment by Type
Monoclonal Antibody
Polyclonal Antibody
Segment by Application
Flow Cytometry
ELISA
Western Blot
Immunoprecipitation
Immunofluorescence
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The B7-H4 Antibody report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices